To investigate whether the combined application of miR497 and TP could further overcome ovarian cancer chemotherapy resistance through synergistic inhibition of mTOR signaling pathway, they prepared ph-sensitive bionic targeted hybrid nanoparticles called HENPs. This evidence concerns the gene MTOR and ovarian carcinoma.